Cargando…
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
Background: Osimertinib has shown greater efficacy than standard epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and fewer grade 3 or higher adverse drug reactions (ADRs) in patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (...
Autores principales: | Majam, Teerapat, Sukasem, Chonlaphat, Reungwetwattana, Thanyanan, Chansriwong, Phichai, Atasilp, Chalirmporn, Trachu, Narumol, Thamrongjirapat, Thanaporn, Sukprasong, Rattanaporn, Meanwatthana, Jennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657898/ https://www.ncbi.nlm.nih.gov/pubmed/38026963 http://dx.doi.org/10.3389/fphar.2023.1222435 |
Ejemplares similares
-
Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
por: Atasilp, Chalirmporn, et al.
Publicado: (2020) -
Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients
por: Atasilp, Chalirmporn, et al.
Publicado: (2022) -
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients
por: Khiewngam, Khantong, et al.
Publicado: (2023) -
Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients
por: Jiarpinitnun, Chuleeporn, et al.
Publicado: (2020) -
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
por: Saifon, Woraseth, et al.
Publicado: (2022)